Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR™ Technology
FREEHOLD, N.J., June 11, 2020 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies […]